This inventor holds 2 USPTO granted patents. Top assignee: The Hong Kong University of Science and Technology. Active years: 2016-2021.
Company Filing History:
Years Active: 2016-2021
Title: Engui Zhao: Innovator in Cancer Imaging and Treatment
Introduction
Engui Zhao is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer research through his innovative work on AIE luminogens. With a total of 2 patents, Zhao's inventions focus on advanced methods for cancer visualization and treatment.
Latest Patents
Zhao's latest patents include groundbreaking technologies aimed at improving cancer diagnostics and therapeutics. One of his notable inventions is related to AIE luminogens for visualization and treatment of cancer. This patent encompasses AIE luminogenic probes designed for cancer cell visualization and discrimination. It also includes lysosome-targeting AIEgens for imaging and autophagy visualization, as well as highly fluorescent AIE-active theranostic agents that monitor drug distribution and exhibit anti-tumor activity against specific cancer cells. Additionally, he has developed probes comprising AIE luminogens for cancer cell imaging and staining, which feature clusteroluminogenic properties and methods of preparation.
Another significant patent focuses on photostable AIE luminogens for specific mitochondrial imaging and its manufacturing method. This invention involves AIE-active TPE derivatives, such as TPE-TPP, TPE-MitoR, and TPE-IQ. These derivatives serve as fluorescent agents for mitochondrial imaging and apoptosis inducers. They possess high specificity to mitochondria, superior photostability, and notable tolerance to changes in the microenvironment. Due to their synthetic flexibility, TPE derivatives can be further modified into dual-functional probes for various applications, including sensing of ROS, metal ions, or pH changes in mitochondria.
Career Highlights
Engui Zhao is affiliated with The Hong Kong University of Science and Technology, where he continues to advance his research in cancer imaging and treatment. His work has garnered attention for its potential to revolutionize cancer diagnostics and therapeutic strategies.
Collaborations
Zhao has collaborated with esteemed colleagues, including Benzhong Tang and Haiqin Deng, to further enhance the impact of his research in the scientific community.
Conclusion
Engui Zhao's innovative contributions to cancer research through his patents on AIE luminogens highlight his commitment to improving cancer diagnostics and treatment. His work continues to inspire advancements in the field and offers hope for better therapeutic options for cancer patients.